First Time Loading...

Abbvie Inc
NYSE:ABBV

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist
Price: 162.35 USD -2.95% Market Closed
Updated: Apr 26, 2024

Abbvie Inc
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Abbvie Inc
Depreciation & Amortization Peer Comparison

Comparables:
GILD
AMGN
MRNA
VRTX
REGN

Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
Abbvie Inc
NYSE:ABBV
Depreciation & Amortization
$8.7B
CAGR 3-Years
10%
CAGR 5-Years
38%
CAGR 10-Years
26%
Gilead Sciences Inc
NASDAQ:GILD
Depreciation & Amortization
$2.7B
CAGR 3-Years
22%
CAGR 5-Years
14%
CAGR 10-Years
23%
Amgen Inc
NASDAQ:AMGN
Depreciation & Amortization
$4.1B
CAGR 3-Years
4%
CAGR 5-Years
16%
CAGR 10-Years
12%
Moderna Inc
NASDAQ:MRNA
Depreciation & Amortization
$621m
CAGR 3-Years
172%
CAGR 5-Years
90%
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Depreciation & Amortization
$181.3m
CAGR 3-Years
18%
CAGR 5-Years
20%
CAGR 10-Years
14%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Depreciation & Amortization
$421m
CAGR 3-Years
21%
CAGR 5-Years
23%
CAGR 10-Years
26%

See Also

What is Abbvie Inc's Depreciation & Amortization?
Depreciation & Amortization
8.7B USD

Based on the financial report for Dec 31, 2023, Abbvie Inc's Depreciation & Amortization amounts to 8.7B USD.

What is Abbvie Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
26%

Over the last year, the Depreciation & Amortization growth was 3%. The average annual Depreciation & Amortization growth rates for Abbvie Inc have been 10% over the past three years , 38% over the past five years , and 26% over the past ten years .